BALCHEM CORP Quarterly Cost of Revenue in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Balchem Corp quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q3 2024.
  • Balchem Corp Cost of Revenue for the quarter ending September 30, 2024 was $155M, a 0.77% increase year-over-year.
  • Balchem Corp Cost of Revenue for the twelve months ending September 30, 2024 was $618M, a 2.07% decline year-over-year.
  • Balchem Corp annual Cost of Revenue for 2023 was $620M, a 6.27% decline from 2022.
  • Balchem Corp annual Cost of Revenue for 2022 was $662M, a 19.1% increase from 2021.
  • Balchem Corp annual Cost of Revenue for 2021 was $556M, a 15.9% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $618M $155M +$1.18M +0.77% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q2 2024 $616M $151M -$2.82M -1.83% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $619M $158M -$1.23M -0.77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $620M $154M -$10.2M -6.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $631M $153M -$22.4M -12.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q2 2023 $653M $154M -$10.9M -6.62% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $664M $159M +$2.01M +1.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $662M $164M +$14.8M +9.95% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $647M $176M +$38.9M +28.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $608M $165M +$21.9M +15.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $586M $157M +$30.4M +24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $556M $149M +$25.2M +20.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $531M $137M +$18.2M +15.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $513M $143M +$24.9M +21.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $488M $127M +$7.82M +6.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $480M $124M +$11.7M +10.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $468M $119M +$14.2M +13.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $454M $118M +$10.3M +9.61% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $444M $119M +$11.2M +10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $432M $112M -$33K -0.03% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $432M $105M -$2.45M -2.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 $435M $108M -$2.59M -2.35% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $437M $108M -$2.02M -1.83% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $439M $112M +$4.59M +4.26% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $435M $107M +$2.51M +2.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $432M $110M +$9.9M +9.87% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $422M $110M +$16.7M +17.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $406M $108M +$13.8M +14.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $392M $105M +$10.7M +11.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $381M $100M +$7.98M +8.64% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $373M $93.3M +$982K +1.06% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $372M $93.8M +$1.03M +1.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $371M $93.9M -$3.1M -3.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $374M $92.3M -$561K -0.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $375M $92.3M -$9.42M -9.26% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $384M $92.8M -$25.7M -21.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $410M $97M -$19M -16.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $429M $92.9M -$6.99M -7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $436M $102M +$39M +62% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $397M $119M +$60.7M +105% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $337M $116M +$52.9M +83.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $284M $99.9M +$41.5M +71% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $242M $62.8M +$2.36M +3.91% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $240M $57.9M +$190K +0.33% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $240M $63.1M +$11.4M +22% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $228M $58.4M +$1.98M +3.51% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $226M $60.4M +$5.37M +9.76% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $221M $57.7M +$8.77M +17.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $212M $51.7M -$104K -0.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $212M $56.4M +$3.5M +6.62% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $209M $55M +$2.82M +5.39% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $206M $48.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 $51.8M +$8.15M +18.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $52.9M +$10.6M +25% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $52.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $43.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $42.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.